» Clinical Diagnostics » Point of Care Test

QuikRead go wrCRP is a rapid test for the quantitative determination of C-reactive protein (CRP) values in whole blood, serum, and plasma with QuikRead go instrument.

QuikRead go wrCRP gives reliable wide range CRP results within minutes.

Wide range CRP testing with QuikRead go wrCRP
C-reactive protein (CRP) is a widely used analyte to help assess the severity of bacterial infection, guide diagnostic and treatment decisions, and monitor response to antibiotic treatment in various healthcare settings 1,2. QuikRead go wrCRP test helps to identify patients who benefit from antibiotics, it helps in monitoring the treatment outcome, and can be used to test for low level inflammation.

CRP point of care testing drives sustainable use of antibiotics and antimicrobial stewardship in healthcare.

The biomarker for venous thromboembolism

D-dimer is a small biomarker of coagulation activation and is present in the blood as a blood clot is degraded.

Response Biomedical offers a whole blood quantitative immunoassay D-dimer test, with our proprietary RAMP technology which assess the levels of D-dimer in patients around the world in ~15 minutes.

Read more about how this product will help with the challenges labs and physicians face, finding the right D-dimer test for your needs.

• Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) are diagnostically challenging conditions that carry a high cost if not recognized and treated promptly.
• Accurate diagnosis of DVT and PE remain a problem and with improper testing, risky, expensive, imaging and treatments may be done unnecessarily.
• DVT and PE present like many other medical problems, but emergency medicine doctors have no time to waste, and the majority of PE-related deaths occur within the first hour

The gold standard biomarker for heart failure (HF)

Response Biomedical offers a FDA cleared whole blood immunoassay NT-proBNP test, with our proprietary RAMP technology which detects the levels of N-terminal prohormone of brain natriuretic peptide in patients with congestive heart failure around the world.

Read more about how this product will help your physicians and patients where a traditional BNP test cannot.

• Provides rapid, accurate diagnoses and assessment of congestive heart failure.
• NT-proBNP is roughly 5 times more stable of a biomarker then BNP
• Better accuracy in mild heart failure patients because the levels of NT-proBNP are 2-10x higher
• Standardized to Roche Elecsys Lab Analyzer

The definitive biomarker for acute myocardial infarction (AMI)

• Cardiac Troponin is the gold standard test for myocardial infarction and is usually the first test ordered for patients with chest pain

• Measurements of cardiac troponin I can improve diagnosis and treatment of myocardial infarction (MI)

• With RAMP Troponin I, healthcare professionals can obtain a quantitative measurement of cardiac troponin I from 75uL of blood without the need for centrifugation

• RAMP tests are individual, single-use quantitative tests that provide rapid, accurate, lab quality results within minutes

Food Detective can be used by healthcare practitioners to test for sensitivities across 59 common foods within the clinic setting.

For professional use only.

The Quantum Blue^® rapid test combines the ease and speed of lateral flow technology (using a highly specific monoclonal antibody), with full quantification by means of a small, telephone sized reading device. The Quantum Blue^® 3^rd generation reader analyzes line intensities by state of the art image analysis and translates them into a quantitative result within minutes and is ideal to obtain test results fast and speed up the clinical decision. Besides calprotectin, BÜHLMANN offers the possibility for therapeutic drug monitoring (TDM) on the Quantum Blue^® reader.

If you are looking for information on our older 2^nd generation of the Quantum Blue^® Reader, please visit this page.

Quantum Blue^® – Calprotectin

The inflammation typical in Ulcerative Colitis and Crohn’s Disease is not present in IBS. It is thought that IBS affects over 30 million people in Europe and results in over 2 million visits annually to physicians. Fecal calprotectin is the ideal tool to differentiate IBS from IBD and to avoid unnecessary invasive diagnostic procedures.

The clinical course of most patients with IBD is marked by periods of remission with intermittent relapses characterized by increased intestinal inflammation. Numerous published studies by Tibble et al. and others, have studied the levels of calprotectin in patients during the course of the disease. The results show that calprotectin is a good predictor of relapse in patients with IBD, thus giving clinicians an effective tool to adapt the patients treatment accordingly and to ease the relapse severity.

Click here for more information on the Quantum Blue^® calprotectin products.

Quantum Blue^® – Therapeutic Drug Monitoring

BÜHLMANN has launched the first rapid test for therapeutic drug monitoring (TDM) in the market. The Quantum Blue^® Adalimumab and the Quantum Blue^® Infliximab assays offer trough level quantification of serum drug levels within 15 minutes. The tests use highly specific monoclonal antibodies and show a very high correlation to common ELISA assays.The Quantum Blue^® Infliximab assay now also allows the detection of anti-drug antibodies (ADA) against Infliximab.

Click here for more information on the Quantum Blue^® TDM portfolio

The QuikRead go Instrument is a compact, fully automatic instrument which is used for quantitative and qualitative measurements together with QuikRead go reagent kits. The QuikRead go system – consisting of the instrument and ready-to-use kits – is specially designed for use in primary healthcare settings. The instrument can be connected to HIS/LIS systems.

Generally

Traceability of test results ensures high quality and reliability. The instrument’s user interface enables a variety of settings to be personalised. There is a choice of 23 different languages, it is easy to add patient and/or operator identification information and the instrument can be easily combined with accessories, such as a barcode reader and a printer.

Ease of use combined with rapid results and reliability makes the QuikRead go system a valuable everyday diagnostic tool for healthcare professionals.

QuikRead go Instrument provides you with

Ease of use

Intuitive user interface
Interactive touch screen which guides users using animations

Minimal hands-on time

Automatic mixing and reagent addition in prefilled cuvettes
Results are automatically stored in the instrument’s internal memory, user and/or patient ID can be linked to the results